Matches in SemOpenAlex for { <https://semopenalex.org/work/W1618555535> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W1618555535 abstract "BACKGROUND: Burkitt lymphoma (BL) represents approximately 40% of all childhood and adolescent non-Hodgkin lymphoma (Miles/Cairo, BJH, 2012). Children with relapsed or progressive BL develop chemotherapy-resistant disease and can rarely be cured with salvage therapy (Cairo et al, JCO, 2012). Bruton9s tyrosine kinase (BTK) is a regulator of normal B-cell development and is activated upon B-cell receptor (BCR) stimulation. Chronic active BCR signaling through BTK activation can be inhibited by the selective and covalent BTK inhibitor, ibrutinib (Young et al, Nat Rev, 2013). Ibrutinib has been highly effective in the treatment of refractory patients with CLL and MCL and has been approved by the FDA for patients with CLL or MCL who have received at least one prior therapy (USPI) (Byrd et al, NEJM, 2013 and Wang et al, NEJM, 2013). BL, however, is associated with tonic or possibly chronic active BCR signaling; while, both CLL and MCL have chronic active BCR signaling. We have previously demonstrated ibrutinib significantly decrease BL proliferation and viability in vitro (Lee/Cairo et al, ASH, 2014) OBJECTIVE: We hypothesize that ibrutinib may be a potential adjuvant agent in the treatment of BL. Therefore, we investigated the in vivo anti-tumor activity of ibrutinib in BL xenografted NOD/SCID (NSG) mice. METHODS: The luciferase expression plasmid (ffluc-Zeo), kindly provided by L. Cooper, MD) was transfected into Raji cells. Cells were subcutaneously injected into NSG mice (6-8wks old, NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ, Jackson lab). Tumor cells engraftment and progression were examined by Bioluminescent Imaging using the Xenogen IVIS-200 (Caliper Life Sciences). Mice were orally gavaged with vehicle control or Ibrutinib (1.25, 12.5 and 25mg/kg/day, generously provided by Janssen RD 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2608. doi:10.1158/1538-7445.AM2015-2608" @default.
- W1618555535 created "2016-06-24" @default.
- W1618555535 creator A5001697191 @default.
- W1618555535 creator A5001967366 @default.
- W1618555535 creator A5002775135 @default.
- W1618555535 creator A5012947331 @default.
- W1618555535 creator A5021489854 @default.
- W1618555535 creator A5022107546 @default.
- W1618555535 creator A5023129428 @default.
- W1618555535 creator A5024574848 @default.
- W1618555535 creator A5027265757 @default.
- W1618555535 creator A5029222555 @default.
- W1618555535 creator A5031442093 @default.
- W1618555535 creator A5034299577 @default.
- W1618555535 creator A5041898934 @default.
- W1618555535 creator A5075246827 @default.
- W1618555535 creator A5080068885 @default.
- W1618555535 creator A5090571101 @default.
- W1618555535 date "2015-08-01" @default.
- W1618555535 modified "2023-09-26" @default.
- W1618555535 title "Abstract 2608: Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL" @default.
- W1618555535 doi "https://doi.org/10.1158/1538-7445.am2015-2608" @default.
- W1618555535 hasPublicationYear "2015" @default.
- W1618555535 type Work @default.
- W1618555535 sameAs 1618555535 @default.
- W1618555535 citedByCount "0" @default.
- W1618555535 crossrefType "proceedings-article" @default.
- W1618555535 hasAuthorship W1618555535A5001697191 @default.
- W1618555535 hasAuthorship W1618555535A5001967366 @default.
- W1618555535 hasAuthorship W1618555535A5002775135 @default.
- W1618555535 hasAuthorship W1618555535A5012947331 @default.
- W1618555535 hasAuthorship W1618555535A5021489854 @default.
- W1618555535 hasAuthorship W1618555535A5022107546 @default.
- W1618555535 hasAuthorship W1618555535A5023129428 @default.
- W1618555535 hasAuthorship W1618555535A5024574848 @default.
- W1618555535 hasAuthorship W1618555535A5027265757 @default.
- W1618555535 hasAuthorship W1618555535A5029222555 @default.
- W1618555535 hasAuthorship W1618555535A5031442093 @default.
- W1618555535 hasAuthorship W1618555535A5034299577 @default.
- W1618555535 hasAuthorship W1618555535A5041898934 @default.
- W1618555535 hasAuthorship W1618555535A5075246827 @default.
- W1618555535 hasAuthorship W1618555535A5080068885 @default.
- W1618555535 hasAuthorship W1618555535A5090571101 @default.
- W1618555535 hasConcept C126322002 @default.
- W1618555535 hasConcept C170493617 @default.
- W1618555535 hasConcept C203014093 @default.
- W1618555535 hasConcept C2777938653 @default.
- W1618555535 hasConcept C2778461978 @default.
- W1618555535 hasConcept C2779878957 @default.
- W1618555535 hasConcept C42362537 @default.
- W1618555535 hasConcept C43907098 @default.
- W1618555535 hasConcept C502942594 @default.
- W1618555535 hasConcept C71924100 @default.
- W1618555535 hasConcept C90059517 @default.
- W1618555535 hasConceptScore W1618555535C126322002 @default.
- W1618555535 hasConceptScore W1618555535C170493617 @default.
- W1618555535 hasConceptScore W1618555535C203014093 @default.
- W1618555535 hasConceptScore W1618555535C2777938653 @default.
- W1618555535 hasConceptScore W1618555535C2778461978 @default.
- W1618555535 hasConceptScore W1618555535C2779878957 @default.
- W1618555535 hasConceptScore W1618555535C42362537 @default.
- W1618555535 hasConceptScore W1618555535C43907098 @default.
- W1618555535 hasConceptScore W1618555535C502942594 @default.
- W1618555535 hasConceptScore W1618555535C71924100 @default.
- W1618555535 hasConceptScore W1618555535C90059517 @default.
- W1618555535 hasLocation W16185555351 @default.
- W1618555535 hasOpenAccess W1618555535 @default.
- W1618555535 hasPrimaryLocation W16185555351 @default.
- W1618555535 hasRelatedWork W2002205469 @default.
- W1618555535 hasRelatedWork W2020034786 @default.
- W1618555535 hasRelatedWork W2044711276 @default.
- W1618555535 hasRelatedWork W2313268391 @default.
- W1618555535 hasRelatedWork W2346474017 @default.
- W1618555535 hasRelatedWork W2482151642 @default.
- W1618555535 hasRelatedWork W2554414890 @default.
- W1618555535 hasRelatedWork W2564945551 @default.
- W1618555535 hasRelatedWork W2591113434 @default.
- W1618555535 hasRelatedWork W265268219 @default.
- W1618555535 hasRelatedWork W2740545252 @default.
- W1618555535 hasRelatedWork W2741571497 @default.
- W1618555535 hasRelatedWork W2743525074 @default.
- W1618555535 hasRelatedWork W2797609450 @default.
- W1618555535 hasRelatedWork W2909212413 @default.
- W1618555535 hasRelatedWork W2956080317 @default.
- W1618555535 hasRelatedWork W2977353899 @default.
- W1618555535 hasRelatedWork W2993034425 @default.
- W1618555535 hasRelatedWork W2995012457 @default.
- W1618555535 hasRelatedWork W3202099625 @default.
- W1618555535 isParatext "false" @default.
- W1618555535 isRetracted "false" @default.
- W1618555535 magId "1618555535" @default.
- W1618555535 workType "article" @default.